Background:

People with spinal cord injury (SCI) are accessing cannabis for therapeutic purposes (CTP), the use of which has been legalized in more than 20 states. In the past, illicit marijuana use had positive correlations with other health risk behaviors. It is not known whether access to CTP has shifted patterns of use and altered health outcomes.

Objective:

To describe the self-reported patterns of CTP use among individuals with SCI and correlations with health behaviors and health indicators.

Method:

Secondary analysis of data from a cross-sectional study involving community-dwelling individuals with chronic SCI and neurogenic bladder and bowel, at least 5 years post injury. Data were collected via structured interviews.

Results:

92.2% of the current sample (n = 244) lived in states that, at the time of the study, permitted the use of CTP. 22.5% reported using CTP at least monthly to relieve pain (70.4%) and spasticity (46.3%). Of those 54 participants, 52.7% were daily users. Whereas 23.0% of non-CTP users endorsed having prescriptions for at least one opioid-based medication, 38.1% of CTP users did so, suggesting that CTP use does not mitigate opioid use. Users were more likely to be single and live alone, report more bladder complications, and perceive their psychosocial functioning as more compromised than non-users.

Conclusion:

A relatively large percentage of individuals with chronic SCI appear to use CTP on a regular basis. Results suggest that they may be more vulnerable to complications and to risk factors for substance use disorders in SCI, such as social isolation. Although the generalizability of these findings is limited by the sampling strategies and the eligibility criteria of the larger study, CTP use should be assessed and considered when planning health interventions.

This work was developed under the University of Michigan Spinal Cord Injury Model System (SCIMS) grant 90SI5000-0103 from the National Institute on Disability and Independent Living Rehabilitation Research (NIDILRR), US Department of Health and Human Services (HHS). The contents of this article do not necessarily represent the policy of NIDILRR, HHS, and you should not assume endorsement by the Federal Government. None of the authors have a financial or other relationship that might signify a conflict of interest.

The researchers followed all ethical guidelines in the conduct of this study, and respondents gave informed consent to participate. This study was reviewed and approved by the University of Michigan Institutional Review Board.

1.
Matsuda
 
LA
,
Lolait
 
SJ
,
Brownstein
 
MJ
,
Young
 
AC
,
Bonner
 
TI
.
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
.
Nature
.
1990
;
346
:
561
-
564
.
2.
Meyer
 
JS
,
Quenzer
 
LF
.
Marijuna and the cannabinoids
. In:
Meyer
 
JS
,
Quenzer
 
LF
, eds.
Psychopharmacology: Drugs, the Brain, and Behavior
.
Sunderland, MA
:
Sinauer Associates
;
2013
:
401
-
426
.
3.
Arevalo-Martin
 
A
,
Molina-Holgado
 
E
,
Garcia-Ovejero
 
D
.
Cannabinoids to treat spinal cord injury
.
Prog Neuro-Psychopharmacol Biol Psychiatry
.
2016
;
64
:
190
-
199
.
4.
Di Marzo
 
V
,
Stella
 
N
,
Zimmer
 
A
.
Endocannabinoid singalling and the deteriorating brain
.
Nature Rev Neurosci.
2015
;
16
:
30
-
42
.
5.
Maccarrone
 
M
,
Guzmán
 
M
,
Mackie
 
K
,
Doherty
 
P
,
Harkany
 
T
.
Programming of neural cells by (endo) cannabinoids: From physiological rules to emerging therapies
.
Nature Rev Neurosci.
2014
;
15
:
786
-
801
.
6.
Wright
 
S
.
Cannabinoid-based medicines for neurological disorders – clinical evidence
.
Mol Neurobiol.
2007
;
36
:
129
-
136
.
7.
Fox News Network LLC
. Research study neuroprotective properties in cannabis.
2012
.http://www.foxnews.com/health/2012/03/20/researchers-study-neuroprotective-properties-incannabis/.
8.
Fox News Network LLC
. Is juicing raw marijuana the next green drink?
2015
.http://www.foxnews.com/health/2015/07/13/is-juicing-raw-marijuana-nextgreen-drink/.
9.
Koppel
 
BS
,
Brust
 
JCM
,
Fife
 
T
, et al.
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders. Report of the Guideline Development Subcommittee of the American Academy of Neurology
.
Neurology
.
2014
;
82
:
1556
-
1563
.
10.
Hosking
 
R
,
Zajicek
 
J
.
Cannabis in neurology – a potted review
.
Nature Rev Neurol.
2014
;
10
:
429
-
430
.
11.
Borgelt
 
LM
,
Franson
 
KL
,
Nussbaum
 
AM
,
Wang
 
GS
.
The pharmacologic and clinical effects of medical cannabis
.
Pharmacotherapy
.
2013
;
33
(
2
):
195
-
209
.
12.
D’Souza
 
DC
,
Ranganathan
 
M
.
Medical marijuana: Is the cart before the horse?
JAMA
.
2015
;
313
(
24
):
2431
-
2432
.
13.
Pacula
 
RL
,
Hunt
 
P
,
Bousted
 
A
.
Words can be deceiving: A review of variation among legally effective medical marijuana laws in the United States
.
J Drug Policy Analysis
.
2014
;
7
(
1
):
1
-
19
.
14.
Reinarm
 
C
,
Nunberg
 
H
,
Lanthier
 
F
,
Heddleston
 
T
.
Who are medical marijuana patients? Population characteristics from nine California assessment clinics
.
J Psychoactive Drugs
.
2011
;
43
(
2
):
128
-
135
.
15.
Ware
 
MA
,
Adams
 
H
,
Guy
 
GW
.
The medical use of cannabis in the UK: Results of a nationwide survey
.
Int J Clin Pract.
2005
;
59
(
3
):
291
-
295
.
16.
Ilgen
 
MA
,
Bohnert
 
K
,
Kleinberg
 
F
, et al.
Characteristics of adults seeking medical marijuana certification
.
Drug Alcohol Depend.
2013
;
132
:
654
-
659
.
17.
Hazekamp
 
A
,
Heerdink
 
ER
.
The prevalence and incidence of medicinal cannabis on prescription in The Netherlands
.
Eur J Clin Pharmacol.
2013
;
69
:
1575
-
1580
.
18.
Hazekamp
 
A
,
Ware
 
MA
,
Muller-Vahl
 
KR
,
Abrams
 
D
.
The medicinal use of cannabis and cannabinoids – an international cross-sectional survey on administration forms
.
J Psychoactive Drugs
.
2013
;
45
(
3
):
199
-
210
.
19.
Reiman
 
A
.
Medical cannabis patients: Patient profiles and health utilization patterns
.
Compl Health Pract Rev.
2007
;
12
(
1
):
31
-
50
.
20.
Harris
 
D
,
Jones
 
RT
,
Shank
 
R
, et al.
Self-reported marijuana effects and characteristics of 100 San Francisco Medical Marijuana Club members
.
J Addictive Dis.
2000
;
19
(
3
):
89
-
103
.
21.
Dunn
 
M
,
Davis
 
R
.
The perceived effects of marijuna on spinal cord injured males
.
Paraplegia
.
1974
;
12
:
175
.
22.
Cardenas
 
DD
,
Jensen
 
MP
.
Treatments for chronic pain in persons with spinal cord injury
.
J Spinal Cord Med.
2006
;
29
:
109
-
117
.
23.
Stroud
 
MW
,
Bombardier
 
CH
,
Dyer
 
JR
,
Rimmele
 
CT
,
Esselman
 
PC
.
Preinjury alcohol and drug use among persons with spinal cord injury: Implications for rehabilitation
.
J Spinal Cord Med.
2011
;
34
(
5
):
461
-
472
.
24.
Hawkins
 
DA
,
Heinemann
 
AW
.
Substance abuse and medical complications following spinal cord injury
.
Rehabil Psychol.
1998
;
43
(
3
):
219
-
231
.
25.
Heinemann
 
AW
,
Hawkins
 
DA
.
Substance abuse and medical complications following spinal cord injury
.
Rehabil Psychol.
1995
;
40
(
2
):
125
-
140
.
26.
Tate
 
D
,
Forchheimer
 
M
,
Chiodo
 
A
, et al. Development of interview forms for the international spinal cord injury datasets for bowel and bladder. In: Final program and abstract book; International Spinal Cord Society 52nd Annual Meeting; October 27-30,
2013
; Instanbul, Turkey.
27.
Bonniaud
 
V
,
Bryant
 
D
,
Parratte
 
B
,
Guyatt
 
G
.
Development and validation of the short form of a urinary quality of life questionnaire: SF-Qualiveen
.
J Urol.
2008
;
180
(
6
):
2592
-
2598
.
28.
Tulsky
 
D
,
Kisala
 
P
. Spinal Cord Injury multidimensional Quality of Life (SCI-QOL).
2015
.https://commondataelements.ninds.nih.gov/Doc/NOC/Spinal_Cord_Injury_Multidimensional_Quality_of_Life_NOC_Link.pdf.
29.
Wood
 
V
,
Wylie
 
ML
,
Sheafor
 
B
.
An analysis of a short self-report measure of life satisfaction: Correlation with rater judgments
.
J Gerontol.
1969
;
24
(
4
):
465
-
469
.
30.
Warschausky
 
S
,
Dixon
 
P
,
Forchheimer
 
M
, et al.
Quality of life in persons with long-term mechanical ventilation or tetraplegic SCI without LTMV
.
Top Spinal Cord Rehabil.
2005
;
10
(
3
):
94
-
101
.
31.
Tracey
 
T
,
Kokotovic
 
A
.
Factor structure of the Working Alliance Inventory
.
Psychol Assessment
.
1989
;
1
(
3
):
207
-
210
.
32.
Pruitt
 
S
,
Wahlgren
 
S
,
Epping-Jordan
 
J
,
Rossi
 
A
.
Health behavior in persons with spinal cord injury: Development and initial validation of an outcome measure
.
Spinal Cord
.
1998
;
36
:
724
-
731
.
33.
Bachhuber
 
MA
,
Saloner
 
B
,
Cunningham
 
CO
,
Barry
 
CL
.
Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010
.
JAMA Intern Med.
2014
;
174
(
10
):
1668
-
1673
.
34.
Hall
 
W
,
Degenhardt
 
L
.
Adverse health effects of non-medical cannabis use
.
The Lancet
.
2009
;
374
(
9698
):
1383
-
1391
.
35.
Grace
 
T
,
Kloner
 
RA
,
Rezkalla
 
S
.
Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: What cardiologists need to know
.
Am J Cardiol.
2014
;
113
:
187
-
190
.
36.
Volkow
 
ND
,
Baler
 
RD
,
Compton
 
WM
,
Weiss
 
SRB
.
Adverse health effects of marijuana use
.
New Engl J Med.
2014
;
270
:
2219
-
2227
.
37.
Freeman
 
RM
,
Adekanmi
 
O
,
Waterfield
 
MR
,
Waterfield
 
AE
,
Wright
 
D
,
Zajicek
 
J
.
The effect of cannabis on urge incontinence in patients with multiple sclerosis: A multicentre, randomised placebo-controlled trial (CAMS-LUTS)
.
Int Urogynecol J.
2006
;
17
:
636
-
641
.
38.
van den Elsen
 
GAH
,
Ahmed
 
AIA
,
Lammers
 
M
, et al.
Efficacy and safety of medical cannabinoids in older subjects: A systematic review
.
Ageing Res Rev.
2014
;
14
:
56
-
64
.
39.
Rachlin
 
H
.
The lonely addict
. In:
Bickel
 
WK
,
Vuchinich
 
RE
, eds.
Reframing Health Behavior Change with Behavioral Economics
.
Mahwah, NJ
:
Lawrence Erlbaum Associates
;
2000
:
145
-
166
.
40.
Tate
 
DG
,
Forchheimer
 
MB
,
Krause
 
JS
,
Meade
 
MA
,
Bombardier
 
CH
.
Patterns of alcohol and substance use and abuse in persons with spinal cord injury: Risk factors and correlates
.
Arch Phys Med Rehabil.
2004
;
85
:
1837
-
1847
.
41.
Ocañez
 
KLS
,
McHugh
 
RK
,
Otto
 
MW
.
A metaanalytic review of the association between anxiety sensitivity and pain
.
Depression Anxiety
.
2010
;
27
:
760
-
767
.